Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany

Pharmacopsychiatry

Volumn 44, Issue 7, 2011, Pages 331-338

  Franke, A G ^a   Christmann, M ^a   Bonertz, C ^a   Fellgiebel, A ^a   Huss, M ^a   Lieb, K ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

caffeinated drink(s); caffeine; caffeine tablets; coffee; cognitive enhancement

Indexed keywords

CAFFEINE; CENTRAL STIMULANT AGENT; COFFEE; NOOTROPIC AGENT; TABLET;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; BEVERAGE; CAFFEINATED DRINK; COFFEE; COGNITION; COGNITIVE ENHANCEMENT; COLLEGE STUDENT; FEMALE; FOOD INTAKE; GENDER; GERMANY; HIGH SCHOOL STUDENT; HUMAN; LIFESPAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; ADOLESCENT; AGE; ATTITUDE TO HEALTH; DRUG UTILIZATION; EPIDEMIOLOGY; MIDDLE AGED; PILOT STUDY; PREVALENCE; STUDENT; TABLET; UNIVERSITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; BEVERAGES; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COFFEE; DRUG UTILIZATION; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PILOT PROJECTS; PREVALENCE; QUESTIONNAIRES; STUDENTS; TABLETS; UNIVERSITIES; YOUNG ADULT;

EID: 80855141366     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1286347     Document Type: Article

References (51)

1. Benowitz N L. Clinical pharmacology of caffeine. Annu Rev Med: 1990; 41 277 288 (Pubitemid 20121734)
2. Hughes J R, Oliveto A H. A systematic survey of caffeine intake in Vermont. Exp Clin Psychopharmacol: 1997; 5 393 398 (Pubitemid 27490386)
3. Hughes J R, Oliveto A H, Helzer J E et al. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10? Am J Psychiatry: 1992; 149 33 40
4. Schreiber G B, Maffeo C E, Robins M et al. Measurement of coffee and caffeine intake: implications for epidemiologic research. Prev Med: 1988; 17 280 294
5. Morgan K J, Stults V J, Zabik M E. Amount and dietary sources of caffeine and saccharin intake by individuals ages 5 to 18 years. Regul Toxicol Pharmacol: 1982; 2 296 307 (Pubitemid 13146442)
6. Ferre S, Ciruela F, Borycz J et al. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front Biosci: 2008; 13 2391 2399 (Pubitemid 351589262)
7. Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci: 2004; 61 857 872 (Pubitemid 38659659)
8. Marley E, Nistico G. Effects of catecholamines and adenosine derivatives given into the brain of fowls. Br J Pharmacol: 1972; 46 619 636
9. Nehlig A, Daval J L, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev: 1992; 17 139 170
10. Taketo M, Matsuda H, Yoshioka T. Calcium-independent inhibition of GABA(A) current by caffeine in hippocampal slices. Brain Res: 2004; 1016 229 239 (Pubitemid 38887706)
11. Franke A G, Lieb K. Pharmacological neuroenhancement and brain doping: Chances and risks. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2011; 53 853 859
12. Beaumont M, Batejat D, Coste O et al. Recovery after prolonged sleep deprivation: residual effects of slow-release caffeine on recovery sleep, sleepiness and cognitive functions. Neuropsychobiology: 2005; 51 16 27 (Pubitemid 40867986)
13. Beaumont M, Batejat D, Pierard C et al. Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance. J Sleep Res: 2001; 10 265 276 (Pubitemid 34014773)
14. Kamimori G H, Penetar D M, Headley D B et al. Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. Eur J Clin Pharmacol: 2000; 56 537 544
15. Lagarde D, Batejat D, Sicard B et al. Slow-release caffeine: a new response to the effects of a limited sleep deprivation. Sleep: 2000; 23 651 661 (Pubitemid 30636660)
16. Penetar D, McCann U, Thorne D et al. Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology (Berl): 1993; 112 359 365 (Pubitemid 23278301)
17. Killgore W D, Rupp T L, Grugle N L et al. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44h of continuous wakefulness. J Sleep Res: 2008; 17 309 321
18. Wesensten N J, Belenky G, Kautz M A et al. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl): 2002; 159 238 247 (Pubitemid 34143372)
19. Gilliland K, Bullock W. Caffeine: a potential drug of abuse. Adv Alcohol Subst Abuse: 1983; 3 53 73 (Pubitemid 14133398)
20. Satel S. Is caffeine addictive? a review of the literature. Am J Drug Alcohol Abuse: 2006; 32 493 502
21. Franke A G, Bonertz C, Christmann M et al. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry: 2011; 44 60 66
22. Wilens T E, Adler L A, Adams J et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry: 2008; 47 21 31
23. Maher B. Poll results: look whos doping. Nature: 2008; 452 7188 674 675 (Pubitemid 351521058)
24. Franke A G, Bonertz C, Christmann M et al. Attitudes towards cognitive enhancement in users and non-users of stimulants for cognitive enhancement. Am J Bioeth. Primary Research (accepted)
25. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health: 2000; 49 143 145
26. Hall K M, Irwin M M, Bowman K A et al. Illicit use of prescribed stimulant medication among college students. J Am Coll Health: 2005; 53 167 174 (Pubitemid 40139028)
27. McCabe S E, Boyd C J. Sources of prescription drugs for illicit use. Addict Behav: 2005; 30 1342 1350 (Pubitemid 40967022)
28. McCabe S E, Knight J R, Teter C J et al. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction: 2005; 100 96 106
29. McCabe S E, Teter C J, Boyd C J. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse: 2004; 39 1095 1116 (Pubitemid 39163121)
30. Teter C J, McCabe S E, Cranford J A et al. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health: 2005; 53 253 262 (Pubitemid 40720541)
31. Deutsche Angestelltenkrankenkasse (DAK) Gesundheitsreport 2009. Analyse der Arbeitsunfhigkeitsdaten. Schwerpunktthema Doping am Arbeitsplatz. Berlin/Hamburg: 2009
32. Sahakian B, Morein-Zamir S. Professors little helper. Nature: 2007; 450 7173 1157 1159
33. de Jongh R, Bolt I, Schermer M et al. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev: 2008; 32 760 776
34. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction: 2007; 102 740 751 (Pubitemid 46633355)
35. Nestle M. Soft drink pouring rights: marketing empty calories to children. Public Health Rep: 2000; 115 308 319
36. Miller K E. Wired: energy drinks, jock identity, masculine norms, and risk taking. J Am Coll Health: 2008; 56 481 489
37. Barone J J, Roberts H R. Caffeine consumption. Food Chem Toxicol: 1996; 34 119 129 (Pubitemid 26057854)
38. Gilbert R M. Caffeine consumption. Prog Clin Biol Res: 1984; 158 185 213
39. Killgore W D, Kahn-Greene E T, Grugle N L et al. Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. Sleep: 2009; 32 205 216
40. Alford C, Cox H, Wescott R. The effects of Red Bull energy drink on human performance and mood. Amino Acids: 2001; 21 139 150 (Pubitemid 32831618)
41. Haskell C F, Kennedy D O, Wesnes K A et al. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl): 2005; 179 813 825 (Pubitemid 40767901)
42. Loke W H. Effects of caffeine on mood and memory. Physiol Behav: 1988; 44 367 372 (Pubitemid 19006986)
43. Rao A, Hu H, Nobre A C. The effects of combined caffeine and glucose drinks on attention in the human brain. Nutr Neurosci: 2005; 8 141 153 (Pubitemid 41131430)
44. Rogers P J, Smith J E, Heatherley S V et al. Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology (Berl): 2008; 195 569 577 (Pubitemid 350160491)
45. Yu G, Maskray V, Jackson S H et al. A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects. Br J Clin Pharmacol: 1991; 32 341 345
46. Wesensten N J, Killgore W D, Balkin T J. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res: 2005; 14 255 266 (Pubitemid 41291310)
47. Wu L T, Schlenger W E. Psychostimulant dependence in a community sample. Subst Use Misuse: 2003; 38 221 248 (Pubitemid 37047198)
48. Shohet K L, Landrum R E. Caffeine consumption questionnaire: a standardized measure for caffeine consumption in undergraduate students. Psychol Rep: 2001; 89 521 526 (Pubitemid 33614943)
49. White B P, Becker-Blease K A, Grace-Bishop K. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. J Am Coll Health: 2006; 54 261 268
50. Juliano L M, Griffiths R R. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl): 2004; 176 1 29 (Pubitemid 39506363)
51. Arzneimittelfachinformation Coffeinum N 0,2g, Tabletten. Mylan Dura Berlin: 2008